about
Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanomaTheranostic impact of NG2/CSPG4 proteoglycan in cancerThe progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling.Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study.Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma.Circulating tumor cells in uveal melanoma.Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma.Therapeutic potential and challenges of natural killer cells in treatment of solid tumorsThe Results of Stricter Inclusion Criteria in an Immunomagnetic Detection Study of Micrometastatic Cells in Bone Marrow of Uveal Melanoma Patients - Relevance for Dormancy.
P2860
Q27326700-407C2815-4EB3-4808-9B12-4CE8CA62E31DQ28085331-1EA4FEA5-45DF-4BEE-AD02-2745A34B4BC5Q33704281-D1E2ECD7-3B32-4136-9E72-1BBD4FCB7826Q33805302-13B15328-71BA-4E1D-B2E1-E474E58B4EDEQ35257150-B7AE1240-0FF2-4079-BF1E-2678C5411BC5Q37822739-278C071F-EC3E-4725-8982-3FA1CC61119FQ38395321-4C6813EB-D9D6-4169-BEDC-C716D10C3B38Q38478878-F00B0957-A624-4816-93B3-122C8E90A67AQ47664902-EB9F3F5F-F303-49F5-A652-1F815ACAD667
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Human uveal melanoma expresses NG2 immunoreactivity.
@en
type
label
Human uveal melanoma expresses NG2 immunoreactivity.
@en
prefLabel
Human uveal melanoma expresses NG2 immunoreactivity.
@en
P2093
P2860
P356
P1476
Human uveal melanoma expresses NG2 immunoreactivity.
@en
P2093
F A Billson
M C Madigan
R M Conway
P2860
P304
P356
10.1136/BJO.87.5.629
P407
P577
2003-05-01T00:00:00Z